Cargando…

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cause of cancer mortality in the world. To improve the quality of diagnostics and patients’ treatment, new and effective biomarkers are needed. Recent studies have shown that the expression level of different types of long non-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guglas, Kacper, Kolenda, Tomasz, Teresiak, Anna, Kopczyńska, Magda, Łasińska, Izabela, Mackiewicz, Jacek, Mackiewicz, Andrzej, Lamperska, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315432/ https://www.ncbi.nlm.nih.gov/pubmed/30441874 http://dx.doi.org/10.3390/ncrna4040033

Ejemplares similares

lncRNA in HNSCC: challenges and potential
por: Guglas, Kacper, et al.
Publicado: (2017)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
por: Kopczyńska, Magda, et al.
Publicado: (2020)

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome
por: Kolenda, Tomasz, et al.
Publicado: (2019)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

Quantification of long non-coding RNAs using qRT-PCR: comparison of different cDNA synthesis methods and RNA stability
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome
por: Sobocińska, Joanna, et al.
Publicado: (2020)

YRNAs and YRNA-Derived Fragments as New Players in Cancer Research and Their Potential Role in Diagnostics
por: Guglas, Kacper, et al.
Publicado: (2020)

YRNAs: New Insights and Potential Novel Approach in Head and Neck Squamous Cell Carcinoma
por: Guglas, Kacper, et al.
Publicado: (2020)

Long Intergenic Non-Coding RNAs in HNSCC: From “Junk DNA” to Important Prognostic Factor
por: Kozłowska, Joanna, et al.
Publicado: (2021)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

The mystery of let-7d – a small RNA with great power
por: Kolenda, Tomasz, et al.
Publicado: (2014)

Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology
por: Kozłowska-Masłoń, Joanna, et al.
Publicado: (2022)

Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos?
por: Guglas, Kacper, et al.
Publicado: (2022)

C10orf55, CASC2, and SFTA1P lncRNAs Are Potential Biomarkers to Assess Radiation Therapy Response in Head and Neck Cancers
por: Paszkowska, Anna, et al.
Publicado: (2022)

Host gene and its guest: short story about relation of long-noncoding MIR31HG transcript and microRNA miR-31
por: Kolenda, Tomasz, et al.
Publicado: (2023)

The Oncogenic Roles of PTTG1 and PTTG2 Genes and Pseudogene PTTG3P in Head and Neck Squamous Cell Carcinomas
por: Grzechowiak, Inga, et al.
Publicado: (2020)

The World of Pseudogenes: New Diagnostic and Therapeutic Targets in Cancers or Still Mystery Molecules?
por: Stasiak, Maciej, et al.
Publicado: (2021)

Zinc Finger Proteins in Head and Neck Squamous Cell Carcinomas: ZNF540 May Serve as a Biomarker
por: Sobocińska, Joanna, et al.
Publicado: (2022)

Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles
por: Łasińska, Izabela, et al.
Publicado: (2022)

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients
por: Przybyła, Anna, et al.
Publicado: (2015)

Biological role and diagnostic utility of ribosomal protein L23a pseudogene 53 in cutaneous melanoma
por: Kolenda, Tomasz, et al.
Publicado: (2023)

Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics
por: Lamperska, Katarzyna Monika, et al.
Publicado: (2017)

miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker
por: Tomaszewska, Weronika, et al.
Publicado: (2021)

The Landscape of Transmembrane Protein Family Members in Head and Neck Cancers: Their Biological Role and Diagnostic Utility
por: Koteluk, Oliwia, et al.
Publicado: (2021)

Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Angiotensin-converting enzyme inhibitors for ovarian cancer? — a new adjuvant option or a silent trap
por: Regulska, Katarzyna, et al.
Publicado: (2023)

Recent advances in melanoma treatment – American Society of Clinical Oncology (ASCO) 2012 perspective
por: Mackiewicz, Jacek, et al.
Publicado: (2012)

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients
por: Mackiewicz, Jacek, et al.
Publicado: (2018)

Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma
por: Mackiewicz, Jacek, et al.
Publicado: (2017)

The comparison of acute toxicity in 2 treatment courses: Three-weekly and weekly cisplatin treatment administered with radiotherapy in patients with head and neck squamous cell carcinoma
por: Mackiewicz, Jacek, et al.
Publicado: (2017)

Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population
por: Mackiewicz-Wysocka, Małgorzata, et al.
Publicado: (2017)

2D and 3D cell cultures – a comparison of different types of cancer cell cultures
por: Kapałczyńska, Marta, et al.
Publicado: (2016)

LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma Growth
por: Kazimierczak, Urszula, et al.
Publicado: (2021)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
por: Tomela, Katarzyna, et al.
Publicado: (2023)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ujeiaccl05agtu3ebn4afvucmv